Related Experiment Video
Updated: Jan 19, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Effects of leptin on norepinephrine in acute ischemic stroke
Abstract:
Stroke is a multifactorial disease and a consequence of morbidities of diabetes, obesity, hypertension, and heart diseases. Leptin is a major adipokine that regulates weight balance and energy homeostasis, the level of which has been considered as an indicator of acute ischemic stroke. In the present study, we confirmed the high level of leptin and noradrenaline in stroke patients and mouse models as well as oxygen-glucose deprivation (OGD) primary cerebral neurons. Leptin administration increased noradrenaline concentration and dopamine β-monooxygenase (DBH) but decreased noradrenaline transporter (NET) expression in primary cerebral neurons. Moreover, induced noradrenaline concentration, DBH activity, and inhibited NET were blunted by TG101348 (JAK2 inhibitor). JAK2 silencing also abolished the effects of leptin on noradrenaline metabolism.
Related Concept Videos
09:21Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Assessing the Angiogenesis Effects of a Test Drug in a Rat Model of Ischemic Stroke
07:34Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique
05:45Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
Endovascular Treatment of Acute Ischemic Stroke Using the Stent Retriever-Assisted Vacuum-Locked Extraction Technique
09:00Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke
